ClinicalTrials.gov record
Completed Phase 2 Interventional

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

ClinicalTrials.gov ID: NCT00072930

Public ClinicalTrials.gov record NCT00072930. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II, Randomized, Open-Label, Two-Arm, Multicenter Study of MEDI-522, a HuMA Directed Against the Human Alpha V Beta 3 Integrin, in Combination With Docetaxel, Prednisone, and Zoledronic Acid in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Study identification

NCT ID
NCT00072930
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
MedImmune LLC
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • Docetaxel + Prednisone* + Zoledronic Acid Biological
  • MEDI-522 Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2003
Primary completion
Mar 31, 2007
Completion
May 31, 2007
Last update posted
Jan 14, 2008

2003 – 2007

United States locations

U.S. sites
36
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Clinical Research Consultants, Inc. Hoover Alabama 35216
Highlands Oncology Group, P.A. Springdale Arizona 72764
Arizona Hematology-Oncology, P.C. Tucson Arizona 85704
South Valley Medical Plaza Gilroy California 95020-3535
San Bernardino Urological Associates San Bernardino California 92404
Saint Francis Memorial Hospital San Francisco California 94109
Stanford Advanced Medical Center Stanford California 94305-5826
Florida Cancer Specialist Fort Myers Florida 33901
The Florida Wellcare Alliance, L.C. Inverness Florida 34452
Hemotology/Oncology Associates Lake Worth Florida
Hawaii Medical Consultants Honolulu Hawaii 96817
University of Chicago Chicago Illinois 60637-1470
Ingalls Hospital Harvey Illinois 60426
The Community Hospital Munster Indiana 46321
Hematology Oncology Services, LLC New Orleans Louisiana 70115
Hubert H. Humphrey Cancer Center Robbinsdale Minnesota 55422
North Mississippi Hematology & Oncology Associates, Ltd. Tupelo Mississippi 38801
Washington University School of Medicine St Louis Missouri 63110-1010
Comprehensive Cancer Center of Nevada Las Vegas Nevada 89109
VA Sierra Nevada Health Care System Reno Nevada 89502
New Mexico Oncology Hematology, Consultants Ltd. Albuquerque New Mexico 87109
SUNY Down State Medical Center Brooklyn New York 11203
VA Western New York Healthcare System Buffalo New York 14215-1199
North Shore Hematology Oncology Assoc., PC East Setauket New York 11733
Columbia Presbyterian Medical Center New York New York 10032-3713
VA Medical Center Northport New York 11768
Raleigh Hematology Oncology Association Raleigh North Carolina 27609
Clinical Research Services Bismarck North Dakota
University of Cincinnati, Barrett Cancer Center Cincinnati Ohio 45267-0501
Santee Hematology/Oncology Sumter South Carolina 29150
Associates in Oncology and Hematology Chattanooga Tennessee 37404
Thompson Cancer Survival Center Knoxville Tennessee 37916
The Sarah Cannon Cancer Center Nashville Tennessee 37203
Danville Hematology and Oncology Danville Virginia 24541-4155
Virginia Cancer Institute Richmond Virginia 23230
Western Washington Oncology, Inc., P.S. Lacey Washington 98503

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00072930, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 14, 2008 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00072930 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →